DaVita
Headquarters as seen from the Denver Millennium Bridge | |
| Company type | Public |
|---|---|
| Industry | Healthcare |
| Founded | 1979 |
| Headquarters | Denver, Colorado, U.S. |
Key people | Javier J. Rodriguez (CEO) |
| Services | Kidney dialysis |
| Revenue | US$12.8 billion (2024) |
| US$2.09 billion (2024) | |
| US$1.25 billion (2024) | |
| Total assets | US$17.3 billion (2024) |
| Total equity | US$396 million (2024) |
| Owner | Berkshire Hathaway (41.2%) |
Number of employees | 76,000 (2024) |
| Website | davita |
| Footnotes / references | |
DaVita Inc. provides kidney dialysis services through a network of 2,675 outpatient centers in the United States, serving 200,800 patients, and 367 outpatient centers in 11 other countries serving 49,400 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo kidney dialysis 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation. The company has a 37% market share in the U.S. dialysis market. It is organized in Delaware and based in Denver.
In 2023, 67% of the company's revenues came from Medicare and other government-based health insurance programs. In 2023, 89% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 33% of revenues in 2023, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs.
The company is ranked 341st on the Fortune 500.
The name "DaVita" was derived from the Italian language phrase "Dare Vita", which means "to give life".